Insider · CIK 0001770783

Lynch Casey

Reports to the SEC for 2 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001770783

Forms 4 and 5

Insider transactions

41 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-12-02	Longboard Pharmaceuticals, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.4K sh	—	—	0
2024-12-02	Longboard Pharmaceuticals, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−14.4K sh	—	—	0
2024-12-02	Longboard Pharmaceuticals, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.4K sh	—	—	0
2024-12-02	Longboard Pharmaceuticals, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.5K sh	—	—	0
2024-12-02	Longboard Pharmaceuticals, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−22.5K sh	—	—	0
2024-05-23	Longboard Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+22.5K sh	—	—	22,500
2023-05-25	Longboard Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2022-05-24	Longboard Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+12.4K sh	—	—	12,367
2022-01-03	IRLAIRulya Therapeutics Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+440K sh	—	—	440,000
2021-11-18	IRLAIRulya Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−60K sh	—	—	23,159
2021-11-18	IRLAIRulya Therapeutics Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+60K sh	$0.46	+$27.6K	109,895
2021-05-10	IRLAIRulya Therapeutics Inc.S Sale	Director, Chief Executive Officer	SSale	−13.6K sh	$33.75	−$458K	995,190
2021-05-10	IRLAIRulya Therapeutics Inc.S Sale	Director, Chief Executive Officer	SSale	−9,918 sh	$34.89	−$346K	985,272
2021-05-10	IRLAIRulya Therapeutics Inc.S Sale	Director, Chief Executive Officer	SSale	−6,315 sh	$35.81	−$226K	978,957
2021-05-10	IRLAIRulya Therapeutics Inc.S Sale	Director, Chief Executive Officer	SSale	−183 sh	$36.73	−$6,721.59	978,774
2021-03-22	IRLAIRulya Therapeutics Inc.S Sale	Director, Chief Executive Officer	SSale	−300 sh	$36.58	−$11K	1,009,174
2021-03-22	IRLAIRulya Therapeutics Inc.S Sale	Director, Chief Executive Officer	SSale	−18.1K sh	$35.85	−$648K	1,009,474
2021-03-22	IRLAIRulya Therapeutics Inc.S Sale	Director, Chief Executive Officer	SSale	−11.2K sh	$35.10	−$394K	1,027,563
2021-03-22	IRLAIRulya Therapeutics Inc.S Sale	Director, Chief Executive Officer	SSale	−400 sh	$36.60	−$14.6K	1,008,774
2021-03-11	Longboard Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+14.4K sh	—	—	14,428
2021-03-11	Longboard Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+12.4K sh	—	—	12,367
2021-02-03	IRLAIRulya Therapeutics Inc.S Sale	Director, Chief Executive Officer	SSale	−1,900 sh	$44.22	−$84K	1,047,406
2021-02-03	IRLAIRulya Therapeutics Inc.S Sale	Director, Chief Executive Officer	SSale	−8,032 sh	$45.00	−$361K	1,039,374
2021-02-03	IRLAIRulya Therapeutics Inc.S Sale	Director, Chief Executive Officer	SSale	−600 sh	$45.73	−$27.4K	1,038,774
2021-02-03	IRLAIRulya Therapeutics Inc.S Sale	Director, Chief Executive Officer	SSale	−400 sh	$37.39	−$15K	1,058,374
2021-02-03	IRLAIRulya Therapeutics Inc.S Sale	Director, Chief Executive Officer	SSale	−1,600 sh	$38.64	−$61.8K	1,056,774
2021-02-03	IRLAIRulya Therapeutics Inc.S Sale	Director, Chief Executive Officer	SSale	−856 sh	$39.82	−$34.1K	1,055,918
2021-02-03	IRLAIRulya Therapeutics Inc.S Sale	Director, Chief Executive Officer	SSale	−2,000 sh	$40.84	−$81.7K	1,053,918
2021-02-03	IRLAIRulya Therapeutics Inc.S Sale	Director, Chief Executive Officer	SSale	−3,100 sh	$41.91	−$130K	1,050,818
2021-02-03	IRLAIRulya Therapeutics Inc.S Sale	Director, Chief Executive Officer	SSale	−1,512 sh	$43.10	−$65.2K	1,049,306
2021-02-02	IRLAIRulya Therapeutics Inc.S Sale	Director, Chief Executive Officer	SSale	−14.9K sh	$36.02	−$538K	1,063,845
2021-02-02	IRLAIRulya Therapeutics Inc.S Sale	Director, Chief Executive Officer	SSale	−5,071 sh	$36.75	−$186K	1,058,774
2021-02-01	IRLAIRulya Therapeutics Inc.S Sale	Director, Chief Executive Officer	SSale	−100 sh	$38.28	−$3,828	1,079,145
2021-02-01	IRLAIRulya Therapeutics Inc.S Sale	Director, Chief Executive Officer	SSale	−4,686 sh	$34.60	−$162K	1,094,088
2021-02-01	IRLAIRulya Therapeutics Inc.S Sale	Director, Chief Executive Officer	SSale	−3,100 sh	$35.59	−$110K	1,090,988
2021-02-01	IRLAIRulya Therapeutics Inc.S Sale	Director, Chief Executive Officer	SSale	−7,460 sh	$36.56	−$273K	1,083,528
2021-02-01	IRLAIRulya Therapeutics Inc.S Sale	Director, Chief Executive Officer	SSale	−4,283 sh	$37.68	−$161K	1,079,245
2021-02-01	IRLAIRulya Therapeutics Inc.S Sale	Director, Chief Executive Officer	SSale	−371 sh	$39.23	−$14.6K	1,078,774
2020-12-11	IRLAIRulya Therapeutics Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+175K sh	—	—	175,000
2020-12-11	IRLAIRulya Therapeutics Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+175K sh	—	—	175,000
2020-02-06	IRLAIRulya Therapeutics Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+175K sh	—	—	175,000

Recent filings

Accepted (ET)
Dec 24
Lynch Casey0001415889-24-028028
SEC(opens sec.gov)
May 244
Lynch Casey0000950170-24-064612
SEC(opens sec.gov)
May 264
Lynch Casey0001209191-23-032513
SEC(opens sec.gov)
May 314
Lynch Casey0001209191-22-032735
SEC(opens sec.gov)
Jan 54
Lynch Casey0001209191-22-001824
SEC(opens sec.gov)
Nov 194
Lynch Casey0001209191-21-065993
SEC(opens sec.gov)
May 124
Lynch Casey0001209191-21-032078
SEC(opens sec.gov)
Mar 234
Lynch Casey0001209191-21-022682
SEC(opens sec.gov)
Mar 114
Lynch Casey0001209191-21-019992
SEC(opens sec.gov)

Companies

Address

C/O CORTEXYME, INC. 269 EAST GRAND AVE.

SOUTH SAN FRANCISCO, CA, 94080